Recent research conducted by the University of Cologne and the Centre for Genomic Regulation (CRG) in Barcelona has led to a groundbreaking discovery in cancer research. Published in the journal eLIFE, the study overturns the long-standing belief that tumors grow predominantly at their outer edges.
Recent research conducted by NYU Langone Health and its Perlmutter Cancer Center has shed light on the remarkable adaptability of cancer cells in low-glucose environments. This study is pivotal in understanding how tumors evade the effects of chemotherapies, particularly those classified as
Prostate cancer remains the most common cancer in men, presenting significant challenges for healthcare systems worldwide. The journey for a prostate cancer patient is often fraught with difficult choices and life-altering treatments. However, recent advancements in medical technology and
In a bold move to tackle one of the most formidable cancers, Anocca AB has announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for their innovative VIDAR-1 Phase I/II multi-asset trial, targeting advanced pancreatic cancer. The pioneering trial, set
Recent scientific advancements in cancer research are unveiling the complex behaviors and interactions within tumors through innovative technologies such as 3D tumor mapping and single-cell analysis. These methods allow researchers to delve deeper into the intricacies of tumor development and
The growing disparities in cancer treatment between high- and low-income countries are becoming more pronounced, with significant inequalities in the cost and availability of cancer drugs globally. Predictions indicate that by 2040 the world will witness an estimated 28.4 million new cancer cases
